Willow Biosciences Inc.

    Willow Biosciences Inc.

    TTSX:WLLW
    - -
    CAD
    - -
    - -
    Willow Biosciences Inc.
    TSX:WLLW
    (Toronto Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.01
    0.01
    0.03
    0.05
    Revenue per Share
    -177.9
    -310.63
    -250.78
    -106.73
    -128.95
    -31.15
    -10.53
    -9.72
    -8.37
    -2.58
    -0.62
    -0.41
    -0.05
    -0.12
    -0.1
    -0.05
    -0.03
    Basic EPS, GAAP
    -252.3
    -151.44
    -120.69
    -53.78
    -16.75
    -24.39
    -8.23
    -4.83
    -5.46
    -0.71
    -0.22
    -0.17
    -0.17
    -0.12
    -0.09
    -0.03
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -1,117.68
    -1,025.74
    -1,124.4
    38.57
    -79.74
    -21.08
    -13.43
    -10.84
    -10.52
    -3.76
    0.26
    -0.06
    0.2
    0.08
    -0.03
    -0.05
    -0.05
    Book Value per Share
    536.55
    532.45
    292.98
    190.32
    64.56
    32.25
    16.81
    7.47
    -1.38
    -0.2
    0.22
    -0.01
    0.25
    0.13
    0.03
    - -
    -0.01
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    72
    82
    120
    124
    124
    135
    138
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    5
    6
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -261,520
    -168,460
    -17,424.06
    -2,241.17
    -1,149.91
    -131.25
    -61.37
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    2
    3
    3
    3
    2
    1
    1
    Depreciation Expense
    -1
    -3
    -3
    -1
    -2
    -1
    -1
    -1
    -2
    -2
    -45
    -34
    -6
    -15
    -13
    -6
    -4
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -891,320
    -339,460
    -4,616.54
    -1,804.38
    -1,111.69
    -132.75
    -65.12
    Profit Margin (%)
    - -
    1
    - -
    - -
    -1
    -1
    -1
    -1
    -1
    -1
    19
    15
    30
    15
    2
    -1
    - -
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    2
    1
    1
    LT Debt
    3
    5
    4
    3
    1
    1
    1
    1
    - -
    - -
    22
    -1
    30
    16
    3
    -1
    -1
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -88.17
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    1
    1
    - -
    LT Borrowings
    1
    1
    1
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    144
    145
    145
    Market Capitalization
    14
    9
    1

    Working Capital

    CAD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    2
    1
    2
    Cash, Cash Equivalents & STI
    1
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    2
    2
    Payables & Accruals
    1
    1
    - -
    ST Debt
    1
    1
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -2,126.01%
    -1,150.19%
    -114.7%
    Free Cash Flow
    294.17%
    -17.19%
    -66.11%
    Net Income, GAAP
    234.19%
    -5.8%
    -52.5%
    Sales/Revenue/Turnover
    - -
    437.56%
    297.78%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    1
    - -
    1
    2024
    - -
    1
    2
    2
    5
    2025
    2
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.04
    -0.03
    -0.02
    - -
    -0.1
    2024
    -0.02
    -0.01
    -0.01
    - -
    -0.05
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business